Blood vessel inhibitor shows promise against metastatic thyroid ...

Courtesy EurekAlert! - Cancer  Tue, 07/01/2008 - 23:00

(University of Texas M. D. Anderson Cancer Center) Thyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some patients, a research team led by investigators from The University of Texas M.

D. Anderson Cancer Center reports in the July 3 edition of the New England Journal of Medicine.

Sponsors
Tags:

 

Related items

Turned-off cannabinoid receptor turns on colorectal tumor growth
(University of Texas M. D. Anderson Cancer Center) New preclinical research shows that cannabinoid cell surface receptor CB1 plays a...

Once suspect protein found to promote DNA repair, prevent cancer
(University of Texas M. D. Anderson Cancer Center) An abundant chromosomal protein that binds to damaged DNA prevents cancer development by enhancing...

TG2 identified as potential therapeutic target in chemo-resistan...
(University of Texas M. D. Anderson Cancer Center) M. D. Anderson researchers connect overexpression of tissue type transglutaminase with poor...

Faulty DNA repair could be a risk factor for lung cancer in nons...
(American Association for Cancer Research) People who have never smoked but whose cells cannot efficiently repair environmental insults to DNA are at...

Major grant advances personalized therapy for brain tumors
(University of Texas M. D. Anderson Cancer Center) Researchers at The University of Texas M. D. Anderson Cancer Center will advance two new...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com